Barclays’s FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April XAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176K Buy
4,664
+1,569
+51% +$58.5K ﹤0.01% 3788
2026
Q1
$114K Hold
3,095
﹤0.01% 3974
2025
Q4
$113K Sell
3,095
-1,922
-38% -$69.3K ﹤0.01% 4547
2025
Q3
$180K Buy
5,017
+4,226
+534% +$150K ﹤0.01% 4376
2025
Q2
$27.8K Sell
791
-4,763
-86% -$162K ﹤0.01% 4798
2025
Q1
$182K Buy
5,554
+606
+12% +$19.8K ﹤0.01% 4097
2024
Q4
$160K Buy
4,948
+217
+5% +$6.97K ﹤0.01% 4405
2024
Q3
$151K Buy
+4,731
New +$148K ﹤0.01% 4440

Other funds holding XAPR

Barclays's XAPR Position: Q2 2026 in Review

Barclays increased its FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April (XAPR) stake by 51% in Q2 2026, buying an estimated $58.5K and bringing the position to 4,664 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #3788.

Barclays first reported a position in XAPR in Q3 2024 and has held it in 8 quarters since. The position peaked at $182K in Q1 2025. 23 funds tracked by Wall St. Rank hold XAPR as of Q2 2026.

  • Barclays held 4,664 shares of FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April worth $176K as of Q2 2026.
  • Barclays bought 1,569 FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April shares in Q2 2026, an estimated $58.5K.
  • FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3788 holding.
  • Barclays first reported a position in FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April in Q3 2024 and has held it in 8 quarters since.
  • Barclays's FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April position peaked at $182K in Q1 2025.
  • 23 funds tracked by Wall St. Rank held FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.